Surgery Partners Inc
$ 15.00
-5.96%
11 Aug - close price
- Market Cap 2,086,071,000 USD
- Current Price $ 15.00
- High / Low $ 16.28 / 14.90
- Stock P/E N/A
- Book Value 13.03
- EPS -0.59
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.02 %
- 52 Week High 24.10
- 52 Week Low 11.41
About
Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company is headquartered in Brentwood, Tennessee.
Analyst Target Price
$18.64
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-10 | 2026-05-05 | 2026-03-02 | 2025-11-10 | 2025-08-05 | 2025-05-12 | 2025-03-03 | 2024-11-12 | 2024-08-06 | 2024-05-07 | 2024-02-26 | 2023-11-07 |
| Reported EPS | 0.07 | -0.03 | 0.12 | 0.13 | 0.17 | 0.04 | 0.44 | 0.19 | 0.21 | 0.1 | 0.44 | 0.19 |
| Estimated EPS | -0.03 | -0.14 | 0.3038 | 0.16 | 0.14 | 0.05 | 0.3769 | 0.26 | 0.2 | 0.08 | 0.38 | 0.15 |
| Surprise | 0.1 | 0.11 | -0.1838 | -0.03 | 0.03 | -0.01 | 0.0631 | -0.07 | 0.01 | 0.02 | 0.06 | 0.04 |
| Surprise Percentage | 333.3333% | 78.5714% | -60.5003% | -18.75% | 21.4286% | -20% | 16.7418% | -26.9231% | 5% | 25% | 15.7895% | 26.6667% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SGRY
2026-08-11 23:41:10
Surgery Partners (SGRY) stock dropped almost 6% despite a recent quarter showing revenue of US$849 million and adjusted EBITDA margin near 14.7%. The company plans to divest its Idaho Falls asset for US$795 million to reduce debt and simplify its business, though the sale will only trim leverage by about 0.3 turns, leaving balance sheet risks elevated. While bulls point to operational growth in higher acuity outpatient services and physician recruitment, bears highlight slow volume growth, pressured margins, and high leverage as ongoing concerns.
2026-08-11 15:41:11
Cantor Fitzgerald has reiterated its Overweight rating and $18.00 price target for Surgery Partners (NASDAQ:SGRY) stock, citing that the market undervalues the positive impact of the Idaho Falls divestiture on cash conversion. This sale is expected to improve free cash flow conversion by approximately 3% and accelerate organic growth. The firm maintains its positive long-term outlook for Surgery Partners, bolstered by portfolio optimization and favorable market trends.
2026-08-11 13:23:53
Benchmark has reiterated a Buy rating on Surgery Partners (NASDAQ:SGRY) with a $24 price target, implying a 50% upside from its current stock price. This follows the company's Q2 results and reaffirmed full-year guidance, including details on the planned sale of two Idaho Falls hospitals for $795 million to optimize its portfolio. Despite a recent loss per share, analysts predict profitability for the company this year, with significant EBITDA margin improvement expected in the second half of the year.
2026-08-11 12:12:53
Surgery Partners (SGRY) is set to announce its Q2 earnings before market hours on Monday. The company beat revenue expectations last quarter but the market anticipates flat year-on-year revenue growth for the upcoming quarter, a slowdown from the previous year. Analysts have reconfirmed their estimates, and while the outpatient & specialty care segment has seen positive investor sentiment, Surgery Partners's stock is down heading into earnings.
2026-08-11 11:12:53
RBC Capital has adjusted its price target for Surgery Partners (SGRY) from $20 to $19, while maintaining an "Outperform" rating on the stock. This adjustment follows several recent announcements from Surgery Partners, including their Q2 2026 earnings report, which showed increased revenue despite a decline in earnings, and the company's reaffirmation of its earnings guidance for 2026. Additionally, Surgery Partners recently entered into definitive agreements to sell ownership stakes in two hospitals for $795 million.
2026-08-10 23:02:53
Surgery Partners, Inc. (SGRY) released its Q2 2026 earnings, reporting an EPS of $0.10, which beat estimates by $0.04. The company also reported revenue of $848.90 million, a 2.75% year-over-year increase, exceeding expectations by $18.58 million. This article provides access to the slide deck published in conjunction with their earnings call.
